Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to ...
Abstract: In high-power applications, such as wind power generation, dual three-phase permanent-magnet synchronous machines (PMSMs) with two power conversion channels grow in popularity owing to ...
Abstract: Grid phase abnormality poses a critical threat to the safe operation of distribution networks. Conventional phasing verification methods struggle to efficiently locate fault sources in ...
Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback